Supporting clients with everything from preclinical to Phase III trials, the role of a Bioanalytical department is certainly one of variation and importance.

With services ranging from development, validation, and application of bioanalytical methods and protocols, through to the preparation of sampling manuals for clinical workplaces and onwards to the analyses of active ingredients and/or metabolites in biological samples, the lab needs coordination, experience, and leadership in equal measure.

Boasting nine modern LC/MS/MS devices with triple quadrupoles, six of which are equipped with a 2-channel HPLC system, it’s fair to say that QUINTA-ANALYTICA’s Bioanalytical department is one such world-class facility.

Headed by highly experienced Vladimír Kubeš, Quinta’s BioA department hosts a database that currently contains around 300 bioanalytical methods developed and validated in-house in accordance with GLP rules, ICH/FDA, and EMEA guidelines.

Offering a comprehensive range of services including testing of the application form of drugs to guarantee compliance with exact specifications, our Bioanalytical laboratory is here to support all analytical aspects of your clinical and pre-clinical tests.

Speak to Vladimir and his team to learn more.

Additional News

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

  • 15 December 2025

    IVBE for locally acting drugs: insights from Conscio Science Day in Munich

    Can bioequivalence for locally acting drugs be demonstrated without a single subject in a clinical trial? Yes, if your in vitro bioequivalence (IVBE) toolkit is set up in the right way.

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.